Cohort study of investigation of SARS-CoV-2 antibody after vaccination in patients with or without cancer

Cohort study of investigation of SARS-CoV-2 antibody after vaccination in patients with or without cancer - Cohort study of SARS-CoV-2 antibody after vaccination

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000045571

Enrollment

100

Registered

2021-09-30

Start date

2021-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who are planned to receive SARS-CoV-2 vaccine.

Exclusion criteria

Exclusion criteria: Patients who are judged inappropriate for study by investigator.

Design outcomes

Primary

Measure	Time frame
Positive rate of SARS-CoV-2 antibody after 6 weeks of vaccination	—

Countries

Japan

Contacts

Public ContactKentaro Sawada

Kushiro Rosai Hospital Department of Medical Oncology

kesawada@frontier.hokudai.ac.jp0154227191

Outcome results